(Q35220639)

7 August 2017

0 references

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report (English)

1 reference

7 August 2017

Alessandra Larocca

4

0 references

Massimo Offidani

Massimo Offidani

7

0 references

Pellegrino Musto

Pellegrino Musto

12

0 references

Roman Hajek

Roman Hajek

15

0 references

Athanasios Dimopoulos

Meletios A Dimopoulos

22

0 references

Jesús San Miguel

Jesus F San Miguel

24

0 references

Sagar Lonial

10

Sagar Lonial

1 reference

7 August 2017

23

Ola Landgren

1 reference

7 August 2017

19

Kenneth Anderson

1 reference

7 August 2017

26

Pieter Sonneveld

1 reference

7 August 2017

20

Hermann Einsele

1 reference

7 August 2017

27

S Vincent Rajkumar

1 reference

7 August 2017

1

Antonio Palumbo

1 reference

7 August 2017

25

Paul Richardson

1 reference

7 August 2017

5

Thierry Facon

1 reference

7 August 2017

18

Philippe Moreau

1 reference

7 August 2017

16

Heinz Ludwig

1 reference

7 August 2017

11

Sonja Zweegman

1 reference

7 August 2017

6

Shaji K Kumar

1 reference

7 August 2017

13

Evangelos Terpos

1 reference

7 August 2017

2

Sara Bringhen

1 reference

Débora Andréa Evangelista Façanha

7 August 2017

9

Andrea Evangelista

1 reference

7 August 2017

8

Philip McCarthy

1 reference

7 August 2017

María Victoria Mateos

3

Maria-Victoria Mateos

1 reference

7 August 2017

14

Andrew Belch

1 reference

7 August 2017

21

Brian G M Durie

1 reference

7 August 2017

A Keith Stewart

17

1 reference

7 August 2017

language of work or name

English

0 references

publication date

27 January 2015

1 reference

7 August 2017

number of pages

7

1 reference

inferred from page(s)

published in

Blood

1 reference

7 August 2017

volume

125

1 reference

7 August 2017

issue

13

1 reference

7 August 2017

page(s)

2068-2074

1 reference

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Frailty in elderly people

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Comprehensive geriatric assessment for older adults admitted to hospital

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Vulnerability in the elderly: frailty

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

International staging system for multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Frailty in older adults: evidence for a phenotype

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Scales to measure competence in everyday activities

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

IMWG consensus on risk stratification in multiple myeloma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

26 September 2018

Senior adult oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Improved survival in multiple myeloma and the impact of novel therapies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375104

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25628469

12 December 2020

inferred from PubMed ID database lookup

Age is not a prognostic variable with autotransplants for multiple myeloma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25628469

12 December 2020

inferred from PubMed ID database lookup

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25628469

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1182/BLOOD-2014-12-615187

1 reference

7 August 2017

1 reference

7 August 2017

1 reference